메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제24권 제2호
발행연도
2014.1
수록면
135 - 143 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Purpose: Aim of this study was to gather and evaluate perceptions of investigators, IRB members, and IRB administratorson the appropriateness of IRB review process and bioethical oversight system of national R&D (NR&D) projects. Method: Investigators, IRB members, and IRB administrators at 17 different institutions were surveyed using conveniencesampling and survey questionnaires were partially group-specialized to consider any differences between thegroups. Results: Participants included 29 investigators, 37 IRB members, and 17 administrators with response rate of100% (83 of 83). According to the responses obtained, insufficient preparation time for constructing protocol and gainingIRB approval was one of the main problems in the IRB review process (investigator 79.3%, IRB administrator88.2%). Also, discrepancy between NR&D and IRB’s protocol formats was another major issue (IRB members 96.4%,IRB administrator 100%) and most investigators (89.7%) had to modify the original NR&D protocol to obtain IRBapproval. Moreover, it was reported that 13.8% of investigators and 31.3% of IRB administrators did not submit midyearreports to IRB and for bioethical issues of NR&D projects, 17.2% of investigators did not include information onproject status and safety issues in the annual reports. Conclusion: In conclusion, for successful and ethical completionof R&D projects, revision of both IRB review process and NR&D project protocol formats as well as implementationof appropriate bioethical oversights are necessary.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0